Kolette L Brown, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: 058496 · El Camino Health · Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brown’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A106125 · Current
Licensed to practise in California · since 2008 · expires 2028-04-30 · University of Maryland School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$56,382
Medicare paid this office $56,382 for 161 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 90 | $17,906 | $120 |
| Short return visit (20+ min) | 90 | $10,837 | $87 |
| New patient visit (45+ min) | 49 | $7,191 | $147 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $4,417 | $158 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 126 | $4,204 | $15 |
See all 10 services
| Return visit (30+ min) | 90 | $17,906 | $120 |
| Short return visit (20+ min) | 90 | $10,837 | $87 |
| New patient visit (45+ min) | 49 | $7,191 | $147 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $4,417 | $158 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 126 | $4,204 | $15 |
| Long return visit (40+ min) | 13 | $2,245 | $173 |
| New patient visit (30+ min) | 18 | $1,737 | $96 |
| Influenza vaccine split virus, preservative free | 18 | $1,473 | $82 |
| Short return visit | 17 | $1,063 | $56 |
| Administration of influenza virus vaccine | 20 | $781 | $39 |
Who their Medicare patients are
161 Original Medicare patients in 2024. Average age 75 · Women 76% · Also on Medicaid 12% · Health risk score 0.96. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 35% · Coronary heart disease 29% · Chronic kidney disease 23% · Atrial fibrillation 19% · Depression 17% · Heart failure 14% · Cancer 12% · COPD 8% · Dementia 8% · Stroke 7%.
The office billed $211,098, Medicare allowed $70,167 and paid $56,382; for 795 services of 28 kinds; $2,707 of it was for drugs given in the office and $53,675 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$67,760
Pharmacies billed $67,760 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
925 generic and 121 brand-name prescriptions · $67,760 in drug cost · 45 antibiotic prescriptions to 33 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levothyroxine | 40 | $555 | $14 |
| Gabapentin | 71 | $528 | $7 |
| Atorvastatin | 85 | $505 | $6 |
| Rosuvastatin | 29 | $479 | $17 |
| Albuterol Sulfate Hfa | 17 | $470 | $28 |
See all 21 drugs
| Levothyroxine | 40 | $555 | $14 |
| Gabapentin | 71 | $528 | $7 |
| Atorvastatin | 85 | $505 | $6 |
| Rosuvastatin | 29 | $479 | $17 |
| Albuterol Sulfate Hfa | 17 | $470 | $28 |
| Diclofenac | 22 | $367 | $17 |
| Pravastatin | 21 | $284 | $14 |
| Metoprolol | 22 | $278 | $13 |
| Amlodipine Besylate | 64 | $263 | $4 |
| Mirtazapine | 11 | $224 | $20 |
| Clopidogrel | 39 | $215 | $6 |
| Lisinopril | 30 | $192 | $6 |
| Montelukast | 11 | $141 | $13 |
| Fluticasone Propionate | 18 | $132 | $7 |
| Carvedilol | 13 | $127 | $10 |
| Metformin | 15 | $88 | $6 |
| Alendronate | 21 | $87 | $4 |
| Trazodone | 17 | $53 | $3 |
| Azithromycin | 13 | $41 | $3 |
| Losartan | 15 | $37 | $2 |
| Hydrochlorothiazide | 15 | $24 | $2 |
Year by year
| 2024 | 1,046 | 233 | None | 12% | $67,760 |
| 2023 | 931 | 111 | 0% (0) | None | $70,858 |
| 2022 | 1,137 | 80 | None | None | $41,345 |
| 2021 | 1,277 | 185 | 3% (41) | 5% | $41,239 |
| 2020 | 1,422 | 190 | 4% (53) | None | $41,608 |
| 2019 | 1,148 | 189 | 4% (50) | None | $66,322 |
| 2018 | 1,346 | 170 | 4% (51) | None | $71,267 |
| 2017 | 809 | 153 | 5% (38) | None | $30,390 |
| 2016 | 1,224 | 181 | 5% (56) | None | $58,909 |
| 2015 | 1,170 | 164 | 5% (58) | None | $48,993 |
| 2014 | 1,368 | 184 | 4% (59) | None | $68,379 |
| 2013 | 1,100 | 167 | 5% (52) | None | $37,525 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Eliquis | 54 | $17,092 | $317 |
| Levothyroxine | 66 | $1,260 | $19 |
| Atorvastatin | 89 | $819 | $9 |
| Gabapentin | 75 | $646 | $9 |
| Pravastatin | 19 | $634 | $33 |
| Albuterol Sulfate Hfa | 13 | $465 | $36 |
| Amlodipine Besylate | 94 | $457 | $5 |
| Clopidogrel | 44 | $376 | $9 |
| Metoprolol | 17 | $323 | $19 |
| Montelukast | 15 | $292 | $19 |
| Donepezil | 15 | $286 | $19 |
| Diclofenac | 12 | $283 | $24 |
| Diltiazem 24hr Er | 14 | $244 | $17 |
| Losartan | 42 | $244 | $6 |
| Furosemide | 47 | $217 | $5 |
| Fluticasone Propionate | 13 | $181 | $14 |
| Metoprolol | 33 | $168 | $5 |
| Potassium Chloride | 14 | $154 | $11 |
| Pantoprazole | 13 | $115 | $9 |
| Lovastatin | 11 | $85 | $8 |
| Metformin | 13 | $83 | $6 |
| Glipizide | 11 | $50 | $5 |
| Lisinopril | 11 | $44 | $4 |
2022: 30 drugs
| Eliquis | 40 | $8,587 | $215 |
| Januvia | 19 | $5,098 | $268 |
| Pravastatin | 21 | $1,013 | $48 |
| Gabapentin | 82 | $1,000 | $12 |
| Methenamine Hippurate | 14 | $664 | $47 |
| Atorvastatin | 72 | $582 | $8 |
| Montelukast | 21 | $460 | $22 |
| Tamsulosin | 39 | $428 | $11 |
| Amlodipine Besylate | 73 | $407 | $6 |
| Midodrine | 23 | $377 | $16 |
| Metoprolol | 62 | $312 | $5 |
| Furosemide | 50 | $295 | $6 |
| Clopidogrel | 27 | $269 | $10 |
| Donepezil | 15 | $222 | $15 |
| Losartan | 34 | $218 | $6 |
| Pantoprazole | 35 | $217 | $6 |
| Famotidine | 20 | $212 | $11 |
| Metoprolol | 13 | $205 | $16 |
| Bumetanide | 11 | $201 | $18 |
| Potassium Chloride | 15 | $191 | $13 |
| Olanzapine | 22 | $174 | $8 |
| Carvedilol | 32 | $173 | $5 |
| Diltiazem 24hr Er | 11 | $171 | $16 |
| Levothyroxine | 16 | $122 | $8 |
| Mirtazapine | 22 | $121 | $5 |
| Allopurinol | 23 | $117 | $5 |
| Clonidine | 28 | $106 | $4 |
| Levetiracetam | 11 | $106 | $10 |
| Paroxetine | 15 | $104 | $7 |
| Glipizide | 14 | $81 | $6 |
2021: 31 drugs
| Eliquis | 12 | $4,966 | $414 |
| Pravastatin | 28 | $1,123 | $40 |
| Gabapentin | 72 | $1,001 | $14 |
| Atorvastatin | 97 | $760 | $8 |
| Tamsulosin | 54 | $595 | $11 |
| Cefdinir | 33 | $482 | $15 |
| Levothyroxine | 45 | $451 | $10 |
| Ezetimibe | 15 | $437 | $29 |
| Cefuroxime | 19 | $435 | $23 |
| Allopurinol | 61 | $416 | $7 |
| Duloxetine | 11 | $343 | $31 |
| Famotidine | 44 | $308 | $7 |
| Levetiracetam | 25 | $282 | $11 |
| Mirtazapine | 41 | $251 | $6 |
| Metoprolol | 64 | $240 | $4 |
| Clonidine | 58 | $238 | $4 |
| Amlodipine Besylate | 57 | $237 | $4 |
| Carvedilol | 50 | $222 | $4 |
| Clopidogrel | 18 | $199 | $11 |
| Olanzapine | 26 | $179 | $7 |
| Pantoprazole | 25 | $176 | $7 |
| Simvastatin | 18 | $136 | $8 |
| Potassium Chloride | 11 | $136 | $12 |
| Hydrocodone-Acetaminophen | 12 | $130 | $11 |
| Hydralazine | 12 | $115 | $10 |
| Losartan | 15 | $113 | $8 |
| Furosemide | 23 | $98 | $4 |
| Prednisone | 14 | $94 | $7 |
| Lisinopril | 11 | $72 | $7 |
| Tramadol | 18 | $70 | $4 |
| Metformin | 14 | $63 | $5 |
2020: 36 drugs
| Xarelto | 16 | $5,566 | $348 |
| Eliquis | 14 | $5,005 | $358 |
| Atrovent Hfa | 12 | $4,838 | $403 |
| Aripiprazole | 14 | $1,543 | $110 |
| Enoxaparin | 23 | $1,485 | $65 |
| Atorvastatin | 132 | $1,030 | $8 |
| Gabapentin | 70 | $660 | $9 |
| Duloxetine | 19 | $604 | $32 |
| Levetiracetam | 47 | $523 | $11 |
| Cefuroxime | 27 | $485 | $18 |
| Hydrocodone-Acetaminophen | 36 | $472 | $13 |
| Hydralazine | 46 | $438 | $10 |
| Cefdinir | 24 | $393 | $16 |
| Metoprolol | 23 | $386 | $17 |
| Levothyroxine | 60 | $353 | $6 |
| Carvedilol | 34 | $289 | $8 |
| Pantoprazole | 43 | $284 | $7 |
| Citalopram Hbr | 41 | $284 | $7 |
| Quetiapine | 36 | $283 | $8 |
| Midodrine | 16 | $275 | $17 |
| Amlodipine Besylate | 72 | $248 | $3 |
| Metoprolol | 64 | $235 | $4 |
| Trazodone | 50 | $198 | $4 |
| Furosemide | 47 | $186 | $4 |
| Simvastatin | 18 | $184 | $10 |
| Potassium Chloride | 16 | $170 | $11 |
| Nitroglycerin | 11 | $165 | $15 |
| Metronidazole | 13 | $157 | $12 |
| Clopidogrel | 18 | $146 | $8 |
| Lisinopril | 40 | $139 | $3 |
| Hydrochlorothiazide | 22 | $84 | $4 |
| Losartan | 15 | $82 | $5 |
| Famotidine | 11 | $81 | $7 |
| Prednisone | 11 | $67 | $6 |
| Benazepril | 11 | $63 | $6 |
| Tramadol | 12 | $44 | $4 |
2019: 35 drugs
| Eliquis | 25 | $12,795 | $512 |
| Aripiprazole | 20 | $3,546 | $177 |
| Fluticasone-Salmeterol | 12 | $2,490 | $208 |
| Tolterodine Tartrate Er | 20 | $1,129 | $56 |
| Atorvastatin | 70 | $1,110 | $16 |
| Metoprolol | 32 | $1,063 | $33 |
| Gabapentin | 43 | $967 | $22 |
| Lisinopril | 37 | $518 | $14 |
| Levothyroxine | 32 | $419 | $13 |
| Omeprazole | 13 | $398 | $31 |
| Hydralazine | 18 | $330 | $18 |
| Simvastatin | 32 | $330 | $10 |
| Amlodipine Besylate | 32 | $325 | $10 |
| Citalopram Hbr | 26 | $312 | $12 |
| Cefdinir | 18 | $302 | $17 |
| Levetiracetam | 12 | $291 | $24 |
| Pantoprazole | 19 | $258 | $14 |
| Carvedilol | 33 | $257 | $8 |
| Bupropion Hcl Sr | 12 | $249 | $21 |
| Donepezil | 13 | $247 | $19 |
| Quetiapine | 13 | $247 | $19 |
| Valsartan | 14 | $243 | $17 |
| Metoprolol | 25 | $238 | $10 |
| Cefuroxime | 14 | $237 | $17 |
| Furosemide | 43 | $234 | $5 |
| Famotidine | 24 | $232 | $10 |
| Trazodone | 14 | $209 | $15 |
| Tamsulosin | 12 | $205 | $17 |
| Hydrocodone-Acetaminophen | 24 | $199 | $8 |
| Clopidogrel | 14 | $175 | $13 |
| Tramadol | 19 | $119 | $6 |
| Lorazepam | 18 | $115 | $6 |
| Azithromycin | 16 | $110 | $7 |
| Levofloxacin | 16 | $87 | $5 |
| Prednisone | 17 | $73 | $4 |
2018: 43 drugs
| Lantus | 20 | $5,844 | $292 |
| Eliquis | 13 | $5,573 | $429 |
| Colchicine | 25 | $4,134 | $165 |
| Humalog | 11 | $2,822 | $257 |
| Humalog Kwikpen U-100 | 16 | $1,861 | $116 |
| Humulin N | 24 | $1,290 | $54 |
| Tolterodine Tartrate Er | 21 | $1,256 | $60 |
| Atorvastatin | 60 | $1,110 | $19 |
| Duloxetine | 15 | $943 | $63 |
| Gabapentin | 48 | $863 | $18 |
| Mirtazapine | 13 | $755 | $58 |
| Metoprolol | 14 | $712 | $51 |
| Citalopram Hbr | 37 | $634 | $17 |
| Cefdinir | 30 | $609 | $20 |
| Lisinopril | 43 | $561 | $13 |
| Clopidogrel | 18 | $494 | $27 |
| Amlodipine Besylate | 40 | $478 | $12 |
| Amiodarone | 13 | $465 | $36 |
| Metformin | 28 | $426 | $15 |
| Isosorbide Mononitrate Er | 14 | $418 | $30 |
| Furosemide | 66 | $404 | $6 |
| Ondansetron | 19 | $367 | $19 |
| Famotidine | 41 | $362 | $9 |
| Allopurinol | 15 | $351 | $23 |
| Tamsulosin | 18 | $334 | $19 |
| Prednisone | 46 | $307 | $7 |
| Bupropion Hcl Sr | 12 | $285 | $24 |
| Carvedilol | 34 | $273 | $8 |
| Simvastatin | 16 | $242 | $15 |
| Cefuroxime | 12 | $239 | $20 |
| Pantoprazole | 26 | $235 | $9 |
| Tramadol | 17 | $231 | $14 |
| Metoprolol | 25 | $222 | $9 |
| Ranitidine | 12 | $217 | $18 |
| Levothyroxine | 19 | $213 | $11 |
| Hydrocodone-Acetaminophen | 13 | $180 | $14 |
| Warfarin | 12 | $172 | $14 |
| Levofloxacin | 23 | $135 | $6 |
| Fosinopril | 11 | $130 | $12 |
| Trazodone | 13 | $123 | $9 |
| Oxycodone | 12 | $117 | $10 |
| Klor-Con 10 | 14 | $113 | $8 |
| Azithromycin | 11 | $82 | $7 |
2017: 23 drugs
| Xarelto | 12 | $3,269 | $272 |
| Atorvastatin | 16 | $241 | $15 |
| Hydralazine | 15 | $231 | $15 |
| Levothyroxine | 13 | $215 | $17 |
| Furosemide | 55 | $200 | $4 |
| Clopidogrel | 13 | $197 | $15 |
| Gabapentin | 24 | $185 | $8 |
| Pantoprazole | 23 | $174 | $8 |
| Cefdinir | 16 | $171 | $11 |
| Lisinopril | 37 | $159 | $4 |
| Amlodipine Besylate | 33 | $154 | $5 |
| Hydrocodone-Acetaminophen | 16 | $153 | $10 |
| Potassium Chloride | 14 | $137 | $10 |
| Citalopram Hbr | 21 | $123 | $6 |
| Carvedilol | 30 | $122 | $4 |
| Ondansetron | 17 | $102 | $6 |
| Prednisone | 13 | $96 | $7 |
| Omeprazole | 14 | $91 | $7 |
| Trazodone | 14 | $89 | $6 |
| Metformin | 13 | $68 | $5 |
| Losartan | 11 | $47 | $4 |
| Tramadol | 12 | $45 | $4 |
| Simvastatin | 12 | $38 | $3 |
2016: 39 drugs
| Lantus | 16 | $4,273 | $267 |
| Atrovent Hfa | 11 | $3,349 | $304 |
| Enoxaparin | 30 | $2,648 | $88 |
| Flovent Hfa | 11 | $1,959 | $178 |
| Amlodipine Besylate | 50 | $708 | $14 |
| Ondansetron | 18 | $613 | $34 |
| Hydrocodone-Acetaminophen | 36 | $609 | $17 |
| Gabapentin | 37 | $589 | $16 |
| Cefuroxime | 20 | $572 | $29 |
| Lovastatin | 14 | $526 | $38 |
| Hydralazine | 17 | $434 | $26 |
| Tamsulosin | 20 | $393 | $20 |
| Pantoprazole | 26 | $376 | $14 |
| Warfarin | 52 | $345 | $7 |
| Metoprolol | 34 | $301 | $9 |
| Omeprazole | 26 | $297 | $11 |
| Atorvastatin | 21 | $285 | $14 |
| Potassium Chloride | 19 | $284 | $15 |
| Clopidogrel | 17 | $263 | $15 |
| Fenofibrate | 12 | $248 | $21 |
| Lisinopril | 31 | $242 | $8 |
| Furosemide | 37 | $240 | $6 |
| Cefdinir | 11 | $238 | $22 |
| Allopurinol | 12 | $209 | $17 |
| Prednisone | 24 | $201 | $8 |
| Citalopram Hbr | 27 | $194 | $7 |
| Montelukast | 14 | $186 | $13 |
| Primidone | 11 | $182 | $17 |
| Metformin | 19 | $149 | $8 |
| Famotidine | 13 | $131 | $10 |
| Azithromycin | 19 | $121 | $6 |
| Levofloxacin | 22 | $120 | $5 |
| Carvedilol | 16 | $119 | $7 |
| Simvastatin | 17 | $118 | $7 |
| Trazodone | 16 | $114 | $7 |
| Ciprofloxacin | 13 | $103 | $8 |
| Glipizide | 12 | $93 | $8 |
| Hydrochlorothiazide | 13 | $52 | $4 |
| Atenolol | 12 | $46 | $4 |
2015: 39 drugs
| Spiriva | 23 | $4,351 | $189 |
| Enoxaparin | 28 | $2,808 | $100 |
| Humalog | 11 | $2,233 | $203 |
| Lidocaine | 16 | $1,325 | $83 |
| Tamsulosin | 26 | $1,035 | $40 |
| Gabapentin | 48 | $919 | $19 |
| Cefuroxime | 21 | $648 | $31 |
| Amlodipine Besylate | 56 | $630 | $11 |
| Hydrocodone-Acetaminophen | 31 | $591 | $19 |
| Omeprazole | 26 | $570 | $22 |
| Duloxetine | 16 | $560 | $35 |
| Pantoprazole | 54 | $536 | $10 |
| Hydralazine | 24 | $485 | $20 |
| Metoprolol | 45 | $433 | $10 |
| Clopidogrel | 25 | $394 | $16 |
| Felodipine Er | 14 | $355 | $25 |
| Furosemide | 50 | $346 | $7 |
| Atorvastatin | 30 | $340 | $11 |
| Levothyroxine | 21 | $339 | $16 |
| Mirtazapine | 12 | $314 | $26 |
| Levofloxacin | 18 | $245 | $14 |
| Primidone | 15 | $217 | $14 |
| Lovastatin | 21 | $188 | $9 |
| Warfarin | 21 | $172 | $8 |
| Lisinopril | 25 | $169 | $7 |
| Tramadol | 17 | $131 | $8 |
| Carvedilol | 16 | $118 | $7 |
| Azithromycin | 14 | $117 | $8 |
| Montelukast | 11 | $117 | $11 |
| Divalproex | 11 | $114 | $10 |
| Glipizide | 15 | $111 | $7 |
| Simvastatin | 12 | $100 | $8 |
| Amiodarone | 11 | $91 | $8 |
| Metformin | 13 | $90 | $7 |
| Ciprofloxacin | 14 | $86 | $6 |
| Prednisone | 11 | $81 | $7 |
| Trazodone | 12 | $78 | $7 |
| Citalopram Hbr | 11 | $71 | $6 |
| Atenolol | 13 | $53 | $4 |
2014: 40 drugs
| Enoxaparin | 38 | $7,582 | $200 |
| Spiriva | 37 | $6,807 | $184 |
| Lantus | 18 | $4,130 | $229 |
| Qvar | 16 | $2,460 | $154 |
| Flovent Hfa | 14 | $2,331 | $166 |
| Novolin R | 19 | $2,099 | $110 |
| Omeprazole | 53 | $1,007 | $19 |
| Amlodipine Besylate | 43 | $806 | $19 |
| Lovastatin | 20 | $651 | $33 |
| Metoprolol | 64 | $633 | $10 |
| Pantoprazole | 54 | $506 | $9 |
| Gabapentin | 40 | $489 | $12 |
| Tamsulosin | 17 | $481 | $28 |
| Cefuroxime | 13 | $481 | $37 |
| Hydrocodone-Acetaminophen | 32 | $449 | $14 |
| Levothyroxine | 23 | $380 | $17 |
| Donepezil | 28 | $379 | $14 |
| Simvastatin | 40 | $354 | $9 |
| Doxazosin Mesylate | 13 | $350 | $27 |
| Warfarin | 38 | $346 | $9 |
| Atorvastatin | 26 | $340 | $13 |
| Paroxetine | 21 | $287 | $14 |
| Levofloxacin | 24 | $282 | $12 |
| Furosemide | 37 | $225 | $6 |
| Clopidogrel | 14 | $224 | $16 |
| Carvedilol | 24 | $216 | $9 |
| Nitrostat | 11 | $203 | $18 |
| Glipizide | 13 | $178 | $14 |
| Lisinopril | 23 | $176 | $8 |
| Risperidone | 19 | $165 | $9 |
| Ciprofloxacin | 19 | $160 | $8 |
| Amiodarone | 15 | $147 | $10 |
| Citalopram Hbr | 19 | $143 | $8 |
| Prednisone | 12 | $134 | $11 |
| Losartan | 15 | $132 | $9 |
| Alendronate | 11 | $120 | $11 |
| Metoclopramide | 17 | $105 | $6 |
| Tramadol | 16 | $101 | $6 |
| Metformin | 12 | $75 | $6 |
| Lorazepam | 11 | $59 | $5 |
2013: 37 drugs
| Spiriva | 23 | $4,435 | $193 |
| Enoxaparin | 14 | $3,316 | $237 |
| Namenda | 28 | $3,029 | $108 |
| Qvar | 19 | $2,828 | $149 |
| Novolin R | 11 | $1,036 | $94 |
| Omeprazole | 54 | $838 | $16 |
| Donepezil | 52 | $744 | $14 |
| Vancomycin | 11 | $709 | $64 |
| Metoprolol | 51 | $465 | $9 |
| Quetiapine | 30 | $413 | $14 |
| Tamsulosin | 12 | $388 | $32 |
| Simvastatin | 39 | $353 | $9 |
| Atorvastatin | 12 | $339 | $28 |
| Hydrocodone-Acetaminophen | 28 | $329 | $12 |
| Pantoprazole | 34 | $324 | $10 |
| Risperidone | 19 | $298 | $16 |
| Hydralazine | 14 | $268 | $19 |
| Nitrofurantoin Mono-Macro | 11 | $263 | $24 |
| Warfarin | 46 | $253 | $6 |
| Doxazosin Mesylate | 14 | $224 | $16 |
| Lisinopril | 27 | $195 | $7 |
| Carvedilol | 18 | $195 | $11 |
| Metronidazole | 14 | $194 | $14 |
| Paroxetine | 18 | $181 | $10 |
| Levofloxacin | 20 | $176 | $9 |
| Gabapentin | 16 | $175 | $11 |
| Oxybutynin Chloride | 12 | $173 | $14 |
| Cefuroxime | 17 | $152 | $9 |
| Ciprofloxacin | 23 | $129 | $6 |
| Amlodipine Besylate | 24 | $117 | $5 |
| Furosemide | 18 | $112 | $6 |
| Levothyroxine | 13 | $108 | $8 |
| Losartan | 11 | $104 | $9 |
| Mirtazapine | 14 | $97 | $7 |
| Glipizide | 13 | $80 | $6 |
| Tramadol | 12 | $75 | $6 |
| Prednisone | 12 | $69 | $6 |
Money from drug and device companies
$100 in 2025
| 2025 | 1 | 4 | None | $100 |
| 2019 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Exact Sciences | Cologuard Collection Kit | $100 | 4 payments
|
See all 4 published payments
| Exact Sciences | Meals · 2025-10-14 | Cologuard Collection Kit | $26 |
| Exact Sciences | Meals · 2025-04-29 | Cologuard Collection Kit | $28 |
| Exact Sciences | Meals · 2025-02-13 | Cologuard Collection Kit | $26 |
| Exact Sciences | Meals · 2025-01-14 | Cologuard Collection Kit | $20 |
See earlier years (2019)
2019: $15
| Abbott Laboratories | Freestyle Libre Pro | $15 | 1 payment
|
Professional record
- NPI
- 1285848093
- Licence
- CA A106125, VA 0101241734California A106125: Current · expires 2028-04-30
- Trained
- University of Maryland School of Medicine, 2003
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 12900 Park Plaza Dr, Ste 150 Ms 7110, Cerritos, CA, 90703
- NPI first listed
- 2007-05-10
- NPI last updated
- 2019-08-15
This is when the NPI record was last certified, not a medical board exam.